Additionally, the discovery of disulfidptosis highlights the metabolic vulnerability of SLC7A11 overexpressing cancer cells (16, 18), offering new insights into cancer treatment by targeting their dependency on glucose and NADPH. This evidence concerns the gene SLC7A11 and cancer.